Signal active
Organization
Contact Information
Overview
Agribody Technologies is a agricultural biotechnology company with patented technology that pinpoints and knocks down the gene that causes quick decay in perishable crops, resulting in 3X - 4X longer shelf life, more tolerance to stress, and up to 40% higher yields. CRISPR genome editing is the technical breakthrough enabling our precise novel plant trait development at low cost and high scalability, providing solutions for agricultural crop loss and food waste. We license and co-develop our technology.
About
Biotechnology, Intellectual Property, Genetics
2015
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Agribody Technologies, Inc. headquartered in United States, North America, operates in the Biotechnology, Intellectual Property, Genetics sector. The company focuses on Biotechnology and has secured $38.4M in funding across 24 round(s). With a team of 1-10 employees, Agribody Technologies, Inc. is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Agribody Technologies, Inc., raised $1.6M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
2
4
0
$1.6M
Details
2
Agribody Technologies, Inc. has raised a total of $1.6M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Seed | |||
2017 | Seed | 1.6M |
Investors
Agribody Technologies, Inc. is funded by 7 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Jerry Feitelson | - | FUNDING ROUND - Jerry Feitelson | 1.6M |
Alireza Masrour | - | FUNDING ROUND - Alireza Masrour | 1.6M |
Agribody Technologies, Inc. | - | FUNDING ROUND - Agribody Technologies, Inc. | 1.6M |
Lateral Capital Management | - | FUNDING ROUND - Lateral Capital Management | 1.6M |
Recent Activity
There is no recent news or activity for this profile.